XTuit Pharmaceuticals xtuit.com


Public list: Smart Money VCs (6327) Pharma Startups (6570) Cancer Therapeutics (1180)

XTuit Pharmaceuticals is a biopharmaceutical company developing microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response. The Company's drug development pipeline and integrated, sophisticated clinical biomarker platform will be used for accelerated clinical development across selected cancers and fibrotic disorders. XTuit's compounds act through pleiotropic mechanisms to inhibit extracellular matr...Show all

XTuit Pharmaceuticals is a biopharmaceutical company developing microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response. The Company's drug developme...Show all

Company (Alive / Active)

Phone: 617-588-3770

Fax:

35 Gatehouse Drive
Suite A1
Waltham, 02451
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
XTuit Pharmaceuticals $23.5M Jun 11, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related XTuit Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Novel compositions and uses of metformin agents Nov 25, 2015 Application
Novel compositions and uses of anti-hypertension agents for cancer therapy Mar 15, 2013 Application